A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG

• Status: Completed
• Trial end date: 2010-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to investigate how the intraocular pressure (IOP)-lowering effect of the L-PPDS is altered by adjunctive Xalatan therapy.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mati Therapeutics Inc.
• Collaborator: QLT Inc.
• Treatments: Latanoprost; Ophthalmic Solutions; Tetrahydrozoline

Criteria

Inclusion Criteria:

• Over 18 years

• Diagnosed with bilateral Open-Angle Glaucoma or Ocular Hypertension

• Currently on prostaglandin therapy

Exclusion Criteria:

• Uncontrolled medical conditions

• Subjects who wear contact lenses

• Subjects requiring chronic topical artificial tears, lubricants, and /or - requiring any other chronic topical medications